Dr. Thomas Edward Lad M.D.
Hematologist-Oncologist | Hematology & Oncology
1901 W Harrison St Chicago IL, 60612About
Dr. Thomas Lad is a hematologist oncologist practicing in Chicago, IL. Dr. Lad specializes in the diagnosis, treatment and prevention of blood diseases such as anemia, hemophilia, sickle-cell disease, leukemia and lymphoma. Hematologist Oncologists are also trained in the study of cancer and its attack on other organs.
Education and Training
Oh State Univ Coll of Med, Columbus Oh 1971
Ohio State University College of Medicine 1971
Board Certification
Internal MedicineAmerican Board of Internal MedicineABIM
Internal MedicineAmerican Board of Internal MedicineABIM- Medical Oncology
Provider Details
Expert Publications
Data provided by the National Library of Medicine- Postsurgical adjuvant therapy in stages I, II, and IIIA non-small cell lung cancer.
- Serum cholesterol level and hepatoma.
- Phase II trial of spirogermanium in advanced non-small cell lung cancer. An Illinois Cancer Council Study.
- Treatment of cancer-associated hypercalcemia with mithramycin and oral etidronate disodium.
- Hypocalcemia in patients with prostate cancer.
- Development of skeletal metastasis by human prostate cancer in athymic nude mice.
- Phase II study of etoposide in previously untreated squamous cell carcinoma of the head and neck.
- Elevated nephrogenous cyclic AMP with normal serum parathyroid hormone levels in patients with lung cancer.
- Nephrogenous cyclic adenosine monophosphate levels in normocalcemic cancer patients: its significance.
- A randomized comparison of high-dose infusion methotrexate versus standard-dose weekly therapy in head and neck squamous cancer.
- A specific HPLC assay to determine the pharmacokinetics of methotrexate in patients.
- Taste thresholds of patients with cancer of the esophagus.
- Postsurgical adjuvant chemotherapy: a review.
- Autopsy findings in squamous-cell carcinoma of the esophagus.
- Evaluation of routine ionized calcium determination in cancer patients.
Clinical Trials
- Endocrine Therapy With or Without Abemaciclib (LY2835219) Following Surgery in Participants With Breast Cancer
- Study to Assess the Safety and Efficacy of Ribociclib (LEE011) in Combination With Letrozole for the Treatment of Men and Pre/Postmenopausal Women With HR+ HER2- aBC
- Pregnancy Outcome and Safety of Interrupting Therapy for Women With Endocrine Responsive Breast Cancer
Treatments
- Pancreatic Cancer
- Crohn's Disease
- Throat Cancer
- Breast Cancer
- Lung Cancer
- Esophageal Cancer
- Colon Cancer
- Stomach Cancer
- Ovarian Cancer
- Aerolase® Technologies
- Wrinkle & Scar Improvement
Dr. Thomas Edward Lad M.D.'s Practice location
Dr. Thomas Edward Lad M.D.'s reviews
Write ReviewPatient Experience with Dr. Lad
Recommended Articles
- Arizona Firefighters Raise Funds for Lymphoma Stairclimb
Jackson County Fire District #5 partnered with Dutch Bros. Coffee in Phoenix, Arizona to help raise funds for the Leukemia & Lymphoma Society’s Scott Firefighter Stairclimb in Seattle, which took place at the Columbia Center on March 11th, 2018. All of the money raised for the stairclimb go to...
- How This Survivor Star Beat Hodgkin Lymphoma—Twice
Ethan Zohn is a survivor in many ways. In 2002, he outlasted 15 fiercely strong competitors on the popular TV show, Survivor: Africa. His strength, wit, athleticism, and perseverance won him a million-dollar prize after he defeated these opponents. However, his victory was short-lived. Little did he...
- Little Boy Tugs at Heartstrings of Entire Community: Be the Match!
Danny Feltwell, a young six-year-old boy, was diagnosed with T-cell lymphoblastic lymphoma when he was just two years old. After undergoing countless procedures and just four months from being considered fully cured, Danny relapsed and had to be re-hospitalized. The doctors found that a large tumor...
- Genetic Advancements in Lymphoma Treatment
Cancers are a huge focus for research. Millions of dollars every year are funneled into funding research that could improve treatment methods or find cures for cancer, including blood cancers. Diffuse large B cell lymphoma (DLBCL) is the most common form of non-Hodgkin’s lymphoma (NHL) accounting...
- Make-A-Wish Makes a Movie Star
Through their fundraising, on average in the United States and its territories, Make-A-Wish is able to grant the wish of a child every 34 minutes.How was it started?The Make-A-Wish Foundation started with the wish of one 7-year-old boy’s wish in 1980. Chris Grecius, who had leukemia, wanted to be...
- Astonishing Clinical Trial Results Show Promise for Non-Hodgkin Lymphoma Research
There’s good news for those who’ve been diagnosed with the aggressive non-Hodgkin lymphoma (NHL) type referred to as diffuse large-B cell (DLBCL). According to the American Cancer Society (ACS), this type of HNL is the most common type of lymphoma.The descriptive letters clarify the type of...
Nearby Providers
- Dr. Lily Parhad Hussein M.D.1900 W Polk St # 766 Chicago IL 60612
- Dr. Mousami Shah M.D.1901 W Harrison St Chicago IL 60612
- Dr. Arti Lakhani M.D.1700 W Van Buren St Chicago IL 60612
- Dr. Eduardo Braun M.D.1653 W Congress Pkwy Chicago IL 60612
- Dr. Dominic S Ho M.D.1740 W Taylor St Chicago IL 60612
- Dr. Mohamed Farhat MD1725 W Harrison St Chicago IL 60612